Tenascin-C is a useful marker for disease activity in myocarditis
about
sameAs
Can serum tenascin-C be used as a marker of inflammation in patients with dilated cardiomyopathy?The Inflammatory Heart Diseases: Causes, Symptoms, and Treatments.Tenascin-C induces inflammatory mediators and matrix degradation in osteoarthritic cartilage.Bioinformatics multivariate analysis determined a set of phase-specific biomarker candidates in a novel mouse model for viral myocarditis.Tenascin-C aggravates autoimmune myocarditis via dendritic cell activation and Th17 cell differentiationAdvances in tenascin-C biology.Effect of postconditioning on dynamic expression of tenascin-C and left ventricular remodeling after myocardial ischemia and reperfusion.High tenascin-C levels cause inadequate myocardial blush grade in patients with acute myocardial infarctionMatricellular proteins in cardiac adaptation and disease.The importance of cardiac biomarkers on remodelling after myocardial infarctioncDNA microarray analysis of cancer associated gene expression profiles in malignant peripheral nerve sheath tumours.Involvement of large tenascin-C splice variants in breast cancer progressionSerum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort studyEffluent Tenascin-C Levels Reflect Peritoneal Deterioration in Peritoneal Dialysis: MAJOR IN PD Study.Mechano-regulated tenascin-C orchestrates muscle repair.Type A dissection and chronic dilatation: tenascin-C as a key factor in destabilization of the aortic wall.Detection of Soluble ED-A(+) Fibronectin and Evaluation as Novel Serum Biomarker for Cardiac Tissue Remodeling.Comparative mRNA and MicroRNA Profiling during Acute Myocardial Infarction Induced by Coronary Occlusion and Ablation Radio-Frequency Currents.Histochemistry and cell biology: the annual review 2010.Matricellular proteins: new molecular targets to prevent heart failure.Molecular signatures and the study of gene expression profiles in inflammatory heart diseases.Tenascins and inflammation in disorders of the nervous system.Emerging biomarkers for heart failure: an update.Tenascin-C in cardiovascular remodeling: potential impact for diagnosis, prognosis estimation and targeted therapy.Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury.Extracellular matrix-mediated cellular communication in the heart.Tenascin-C enhances crosstalk signaling of integrin αvβ3/PDGFR-β complex by SRC recruitment promoting PDGF-induced proliferation and migration in smooth muscle cells.Co-stimulation of human breast cancer cells with transforming growth factor-beta and tenascin-C enhances matrix metalloproteinase-9 expression and cancer cell invasion.Tenascin C upregulates interleukin-6 expression in human cardiac myofibroblasts via toll-like receptor 4Distribution of myofibroblast and tenascin-C in cystic adventitial disease: comparison with ganglion.Serum tenascin-C level is associated with coronary plaque rupture in patients with acute coronary syndrome.De novo expression of fetal ED-A(+) fibronectin and B (+) tenascin-C splicing variants in human cardiac allografts: potential impact for targeted therapy of rejection.Serum levels of large tenascin-C variants, matrix metalloproteinase-9, and tissue inhibitors of matrix metalloproteinases in concentric versus eccentric left ventricular hypertrophy.Tenascin-C levels in pseudosynovial fluid of loose hip prostheses.
P2860
Q30448431-CB708FFE-C385-4ECD-B637-8CE5B1E6614CQ30892742-2E4B89EA-7D1B-4D23-BF2B-BC3425F41C76Q33962572-A435F70C-5C84-4A89-B413-CF9EA96F2829Q35096144-03C0FA7A-FE2F-491B-8CD4-BADFD3F1782EQ35114877-8EA9CF11-EA3F-4C6C-92F1-37A5BFEFA926Q35214557-AA90A47C-1C67-465F-8BBA-1B5524E2A26DQ35365832-DC605C0E-F250-4DA1-8D1E-B7F0BC249A0CQ35480748-30CE3B6E-AA26-44BF-83AD-8AA539871902Q35542423-D0635021-273B-4419-A791-E9236E0D36B0Q35757014-47BFD76A-CD94-4FD1-996F-C448FC9A3D58Q35769723-5B353461-DB90-4516-9463-D4F393604E86Q35791432-FC4A9E1E-94FE-4322-BC6C-6FCF58C13631Q36321563-EBF0643F-FFD0-4DA2-802B-E2836A19F693Q36386616-AFE532B4-0A71-441D-8E38-C34C6BB2AF47Q36870043-9C1B9C12-B29E-4AB3-944F-15CE9B011AB3Q37024218-DB772870-8EBD-4FD6-90F4-00A63F90E404Q37222913-E23F6BAA-EC5B-4519-8BDD-B84ABBD09E07Q37441111-092553A8-B6D7-4631-AFF9-F910656F66E9Q37833524-D2FE998B-98C4-44B7-B1C5-2E375207FBD8Q37925022-337F2DD2-73AD-4C23-AB86-9B958781134EQ38037357-460D52D4-35F1-4869-B00A-24CB87AD692EQ38069948-79C5BF76-23D8-4167-AD5A-8561653F9FC6Q38249995-F900661E-A32A-477F-ABA9-47C5E3BB4690Q38308741-0765EFE6-B126-419A-8E0B-BCDAE20623D6Q38594699-1BC878D6-AF1B-46CF-A564-005AD5141AF3Q38632188-5AD27554-19C9-4C57-A1E9-B164A4F0D37BQ39500221-7E830098-0AB7-4FA4-8C44-A397431C0EF9Q40487608-60B96A23-05C0-4B9F-9DD7-A39CA29279BCQ42767722-367D3BFB-F23E-4933-ADE1-C954A94824D0Q43941861-E68020C4-ACA5-4A9A-A00E-34596EC8A0E4Q44375221-87752359-8ACA-4314-99A2-C63215CBDBDFQ45225869-D82E5326-3A22-4194-8AFA-1A0D25DE730AQ45797489-953D0BDD-0892-4259-A092-262D4199B2E6Q51293564-18288563-66EA-40AC-BC68-79B05A3DFF01
P2860
Tenascin-C is a useful marker for disease activity in myocarditis
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Tenascin-C is a useful marker for disease activity in myocarditis
@ast
Tenascin-C is a useful marker for disease activity in myocarditis
@en
Tenascin-C is a useful marker for disease activity in myocarditis
@nl
type
label
Tenascin-C is a useful marker for disease activity in myocarditis
@ast
Tenascin-C is a useful marker for disease activity in myocarditis
@en
Tenascin-C is a useful marker for disease activity in myocarditis
@nl
prefLabel
Tenascin-C is a useful marker for disease activity in myocarditis
@ast
Tenascin-C is a useful marker for disease activity in myocarditis
@en
Tenascin-C is a useful marker for disease activity in myocarditis
@nl
P2093
P2860
P3181
P356
P1476
Tenascin-C is a useful marker for disease activity in myocarditis
@en
P2093
Kyoko Imanaka-Yoshida
Michiaki Hiroe
Naomi Noda
Takuro Tsuchiya
Teruyo Sakakura
Tetsuya Toyozaki
Toshiki Maki
Toshio Nishikawa
Yasuhiro Yasutomi
P2860
P304
P3181
P356
10.1002/PATH.1131
P407
P577
2002-07-01T00:00:00Z